Next Article in Journal
Valorization of Grape Pomace and Berries as a New and Sustainable Dietary Supplement: Development, Characterization, and Antioxidant Activity Testing
Previous Article in Journal
The Extent of Lifestyle-Induced Weight Loss Determines the Risk of Prediabetes and Metabolic Syndrome Recurrence during a 5-Year Follow-Up
 
 
Article
Peer-Review Record

Postoperative Diet with an Oligomeric Hyperproteic Normocaloric Supplement versus a Supplement with Immunonutrients in Colorectal Cancer Surgery: Results of a Multicenter, Double-Blind, Randomized Clinical Trial

Nutrients 2022, 14(15), 3062; https://doi.org/10.3390/nu14153062
by Jorge Alejandro Benavides-Buleje 1,*, Pedro Vicente Fernández-Fernández 1, Elena Ruiz-Úcar 2, Amparo Solana-Bueno 3, Pedro Antonio Parra-Baños 1, Beatriz Martínez-Torres 2, Roberto Lozoya-Trujillo 3, María Dolores Ruiz-Carmona 3, Marina Alarcón-Iranzo 3, Lorena Rentero-Redondo 4, Emilio Peña-Ros 1, José Manuel Muñoz-Camarena 1, Milagros Carrasco-Prats 1, María Ramírez-Faraco 1, Paloma Portillo-Ortega 5 and Antonio Albarracín-Marín-Blázquez 1
Reviewer 1:
Reviewer 2: Anonymous
Nutrients 2022, 14(15), 3062; https://doi.org/10.3390/nu14153062
Submission received: 11 June 2022 / Revised: 11 July 2022 / Accepted: 20 July 2022 / Published: 26 July 2022
(This article belongs to the Section Micronutrients and Human Health)

Round 1

Reviewer 1 Report

The manuscript is well written and the comparation between OHN and IN post-operative supplementation is dealth with well. The results were clearly argomented. I support the authors to continue the study to better understand and improve the post-operative nutritional management of patients with colorectal cancer. I don't have suggestions for the authors.

Reviewer 2 Report

   The clinical study (noninferiority trial) evaluated and compared the effects, including tolerance, of two supplements during rehabilitation after colorectal cancer resection (an oligomeric hyperproteic normocaloric supplement (OHN; experimental arm) and an immunonutritional (IN; active comparator) supplement).

     The study was designed in accordance with applicable ethics regulations and current clinical trial design trends and guidelines.

     The manuscript is well written and in a coherent manner. The stated conclusions are supported by results.

Back to TopTop